Low-temperature (180 K) crystal structure, electron paramagnetic resonance spectroscopy, and propitious anticonvulsant activities of Cu2II(aspirinate)4(DMF)2 and other Cu2II(aspirinate)4 chelates

Journal of Inorganic Biochemistry

Volumn 96, Issue 2-3, 2003, Pages 375-385

  Viossat, Bernard ^a   Daran, Jean Claude ^b   Savouret, Grégoire ^c   Morgant, Georges ^c,d   Greenaway, Frederick T ^e   Dung, Nguyen Huy ^c   Pham Tran, Van Anh ^f   Sorenson, John R J ^f  

^a Laboratoire de Chimie Generale   (France)

^b LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e CLARK UNIVERSITY   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acetylsalicylic acid; Anticonvulsant drugs; Crystal structure; EPR; Non steroidal anti inflammatory drugs; Ternary CuII complex

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID DERIVATIVE; ANTICONVULSIVE AGENT; CHELATING AGENT; COPPER COMPLEX; N,N DIMETHYLFORMAMIDE; PENTETRAZOLE; TETRAKIS MU (ACETYLSALICYLATO)BIS(DIMETHYLFORMAMIDO)DICOPPER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHELATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG ACTIVITY; ELECTRON SPIN RESONANCE; GRAND MAL EPILEPSY; LOW TEMPERATURE; MALE; MOUSE; NONHUMAN; PETIT MAL; RAT; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

EID: 12444298085     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00153-3     Document Type: Article

References (53)

1. Sorenson J.R.J. Prog. Med. Chem. 26:1989;437-568.
2. Brunia C.H., Buyze B. Epilepsia. 13:1972;621-625.
3. Del'va V.A. Chem. Abstr. 62:1965;151-160b.
4. Griscom N.T., Craig J.N., de Neuhauser E.B. Pediatrics. 48:1971;883-895.
5. Danks D.M. Inorg. Persp. Biol. Med. 1:1977;73-100.
6. Horn N., Heydorn K., Damsgaard E. Clin. Genet. 14:1978;186-187.
7. Ashkenazi A., Levin S., Djaldetti J., Fishel E., Benvenisti D. Pediatrics. 52:1973;525-533.
8. Greenfield S., Norton W.T., Morell P. J. Neurochem. 18:1971;2119-2128.
9. Hunt D.M. Nature. 249:1974;852-854.
10. Carlton W.W., Kelly W.A. J. Nutr. 97:1968;42-52.
11. R.A. DiPaolo, P.M. Newberne, in: D.D. Hemphill (Ed.), Trace Substances in Environmental Health, Vol. VII, Copper deficiency and myelination in the new born rat: Histological and biochemical studies. University of Missouri Press, Columbia, MO, 1973, pp. 225-232.
12. Hunt D.M. Life Sci. 19:1976;1913-1930.
13. Sourkes T.L. Pharm. Rev. 24:1972;349-359.
14. Jobe P.C., Picchioni A.L., Chin L. J. Pharmacol. Exp. Ther. 184:1973;1-10.
15. Hadzovic S.R., Kosak R., Stern P. J. Neurochem. 3:1966;1027-1029.
16. Price T.R., Silberfarb P.M. Am. J. Psychol. 133:1976;235.
17. Underwood E.J. Trace Elements in Human and Animal Nutrition. 4th Edition:1977;Academic Press, New York. pp. 56-108.
18. Sorenson J.R.J. Prog. Med. Chem. 15:1978;211-260.
19. J.R.J. Sorenson, D.O. Rauls, K. Ramakrishna, R.E. Stull, A.N. Voldeng, in: D.D. Hemphill (Ed.), Trace Substances in Environmental Health - XIII. Anticonvulsant Activity of Some Copper Complexes. University of Missouri Press, Columbia, MO, 1979, pp. 360-367.
20. Dollwet H.H.A., McNicholas J.B., Pezesk A., Sorenson J.R.J. Trace Elem. Med. 4:1987;13-20.
21. J.R.J. Sorenson, in: G. Berthon (Ed.), Handbook of Metal-Ligand Interactions in Biological Fluids: Bioinorganic Medicine, Vol. 2, Pharmacological Activities of Copper Compounds, Marcel Dekker, New York, 1995, pp. 1128-1139.
22. J.R.J. Sorenson, in: G. Berthon (Ed.), Handbook of Metal-Ligand Interactions in Biological Fluids: Bioinorganic Medicine, Vol. 2, Copper-Potentiation of Nonsteroidal Antiinflammatory Drugs, Marcel Dekker New York, 1995, pp. 1318-1324.
23. Shen Z.Q., Liang Y., Chen Z.H., Liu W.P., Duan L. J. Pharm. Pharmacol. 50:1998;1275-1279.
24. Li L., Shen Z., Yang W., Wu W., Liu W., Chen Z. Metal Based Drugs. 8:2002;253-256.
25. Sorenson J.R.J. Curr. Med. Chem. 9:2002;1867-1891.
26. Baquial J.G.L., Sorenson J.R.J. J. Inorg. Biochem. 60:1995;133-148.
27. Booth B.L., Pitters E., Mayer B., Sorenson J.R.J. Metal Based Drugs. 6:1999;111-120.
28. Sorenson J.R.J., Soderberg L.S.F., Chang L.W., Willingham W.M., Baker M.L., Barnett J.B., Salari H., Bond K. Eur. J. Med. Chem. 28:1993;221-229.
29. Morgant G., Viossat B., Daran J.-C., Roch-Arveiller M., Giroud J.-P., Dung N.-H., Sorenson J.R.J. J. Inorg. Biochem. 70:1998;137-143.
30. Morgant G., Dung N.-H., Daran J.-C., Viossat B., Labouze X., Roch-Arveiller M., Greenaway F.T., Cordes W., Sorenson J.R.J. J. Inorg. Biochem. 81:2000;11-22.
31. Viossat B., Morgant G., Sorenson J.R.J., Roch-Arveiller M., Daran J.-C., Greenaway F.T., Dung N.-H. Ann. Pharm. Fr. 60:2002;102-114.
32. Lemoine P., Viossat B., Morgant G., Greenaway F.T., Tomas A., Dung N.-H., Sorenson J.R.J. J. Inorg. Biochem. 89:2002;18-28.
33. Sorenson J.R.J. J. Med. Chem. 19:1976;135-148.
34. Altomare A., Cascarano G., Giacovazzo G., Guagliardi A., Burla M.C., Polidori G., Camalli M. SIR92 - a program for automatic solution of crystal structures by direct methods. J. Appl. Crystallogr. 27:1994;435.
35. D.J. Watkin, C.K. Prout, R.J. Carruthers, P. Betteridge, Crystals, Issue 11, Chemical Crystallography Laboratory, University of Oxford, Oxford, 2002.
36. D.J. Watkin, C.K. Prout, L.J. Pearce, CAMERON, Chemical Crystallography Laboratory, University of Oxford, Oxford, 1996.
37. Manojlovic-Muir L. Acta Crystallogr. B29:1973;2033-2036.
38. Guessous F., Daran J.-C., Viossat B., Morgant G., Labouze X., Leroy A.L., Roch-Arveiller M., Nguyen Huy D. Metal Based Drugs. 5:1998;337-345.
39. Greenaway F.T., Riviere E., Girerd J.-J., Labouze X., Morgant G., Viossat B., Daran J.-C., Roch-Arveiller M., Nguyen Huy D. J. Inorg. Biochem. 76:1999;19-27.
40. Greenaway F.T., Pereshk A., Cordes A.W., Noble M.C., Sorenson J.R.J. Inorg. Chim. Acta. 93:1984;67-71.
41. Lee J.D. A New Concise Inorganic Chemistry. 3rd Edition:1986;Van Nostrand Reinhold, London.
42. Kawata T., Uekasa H., Furikawa T., Tokii T., Muto Y. Acta Crystallogr. B48:1992;253-261.
43. Greenaway F.T., Norris L.J., Sorenson J.R.J. Inorg. Chim. Acta. 145:1988;279-284.
44. P. DeMeester, S.R. Fletcher, A.C. Skapski, J. Chem. Soc., Dalton Trans. (1973) 2575-2578.
45. C. Dendrinou-Samara, D.P. Kessioglou, G.E. Manoussakis, D. Mentzasos, A. Terzis, J. Chem. Soc., Dalton Trans. (1990) 959-965.
46. Kovala-Demertzi D., Theodorou A., Demertzis M.A., Raptopoulou C., Terzis A. J. Inorg. Biochem. 65:1997;151-157.
47. Weder J.E., Hambley T.W., Kennedy B.J., Lay P.A., McLachlan D., Bramley R., Delfs C.D., Murray K.S., Moubaraki B., Warwick B., Biffin J.R., Regtop H.L. Inorg. Chem. 38:1999;1736-1744.
48. Melnik M. Coord. Chem. Rev. 36:1981;1-44.
49. Melnik M. Coord. Chem. Rev. 42:1982;259-293.
50. Meier J.L., Coughenour C.E., Carlisle J.A., Carlisle G.O. Inorg. Chim. Acta. 106:1985;159-163.
51. Abuhijleh A.L. J. Inorg. Biochem. 55:1994;255-262.
52. Koman M., Melnik M., Glowiak T. J. Coord. Chem. 44:1998;133-139.
53. J.R.J. Sorenson, R.E. Stull, K. Ramakrishna, B.L. Johnson, E. Riddell, D.F. Ring, T.M. Rolniak, D.L. Stewart, in: D.D. Hemphill (Ed.), Trace Substances in Environmental Health - XIII. Anticonvulsant Activity of Some Copper Complexes. University of Missouri Press, Columbia, MO, 1980, pp. 252-266.